XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenue:        
Total revenue $ 1,667 $ 475 $ 3,050 $ 714
Operating expenses:        
Research and development 12,990 17,521 37,996 28,159
Selling, general, and administrative 7,682 8,751 23,994 22,126
Goodwill impairment 181,432 0 181,432 0
Total operating expenses 202,104 26,272 243,422 50,285
Loss from operations (200,437) (25,797) (240,372) (49,571)
Royalty liability interest expense - related parties (8,875) (8,136) (25,953) (10,753)
Other interest income, net 160 281 522 359
Non-operating income (expense), net 7,706 (876) 8,917 (466)
Loss before income taxes (201,446) (34,528) (256,886) (60,431)
Income tax expense (13) 0 (23) 0
Net loss (201,459) (34,528) (256,909) (60,431)
Net loss attributable to redeemable noncontrolling interest (21,491) (8,099) (28,623) (9,918)
Net loss attributable to Cibus, Inc. $ (179,968) $ (26,429) $ (228,286) $ (50,513)
Basic net loss per share of Class A common stock (in dollars per share) $ (7.63) $ (1.59) $ (10.33) $ (6.33)
Diluted net loss per share of Class A common stock (in dollars per share) $ (7.63) $ (1.59) $ (10.33) $ (6.33)
Weighted average shares of Class A common stock outstanding - basic (in shares) 23,586,746 16,641,127 22,105,979 7,979,132
Weighted average shares of Class A common stock outstanding - diluted (in shares) 23,586,746 16,641,127 22,105,979 7,979,132